Activated lung ILC2s produce copious amounts of type 2 cytokines IL-5 and IL-13 (13), which induce eosinophilia (14), mucus hyperproduction (15) and airway hyperresponsiveness (16). The gene discussed is IL5; the disease is Increased total eosinophil count.